Freenome: Lance Baldo
Freenome has hired Lance Baldo as its chief medical officer. Baldo has more than 20 years of clinical, product development, and operational experience and will be responsible for overseeing all aspects of Freenome's clinical development, medical and scientific affairs, and quality and regulatory teams with an initial focus on expanding the firm's capabilities beyond colorectal cancer.
Most recently, Baldo served as CMO of Adaptive Biotechnologies. Prior to that he held numerous roles with the Roche Group and its affiliates, including as senior VP and head of US medical affairs at Genentech. He holds an M.D. from the University of Connecticut School of Medicine and a B.A. in biology from Johns Hopkins University.
Natera: Sangeeta Bhorade
Natera hired Sangeeta Bhorade as vice president of organ health medical affairs. Bhorade has previously served as the founding medical director of the University of Chicago lung transplant program, as well as the founding medical director for the Northwestern University lung transplant program. Prior to joining Natera, she served as medical director at Veracyte.
Mission Bio: Todd Druley
Mission Bio has appointed Todd Druley as chief medical officer. Druley comes to the firm from Angle Biosciences, where he was also CMO. He also previously held the same role at ArcherDx and is a scientific adviser for RhoDx. Druley is a board-certified pediatric oncologist and has performed research on molecular diagnostics for myeloid leukemia, among other cancers. He holds an M.D./Ph.D. from the University of Illinois.
For additional recent items on executive appointments and promotions in omics and molecular diagnostics, please see the People in the News page on our website.